Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,210 | -10,107 | -12,340 | -4,041 | -2,828 |
| Depreciation Amortization | 22 | 21 | 89 | 3 | 3 |
| Accounts receivable | -753 | 19 | 55 | -204 | -12 |
| Accounts payable and accrued liabilities | -37 | 1,889 | 695 | 477 | 83 |
| Other Working Capital | -781 | 1,913 | 750 | 273 | 71 |
| Other Operating Activity | 1,624 | -2,089 | 3,165 | 1,953 | 1,988 |
| Operating Cash Flow | $-10,135 | $-8,354 | $-7,586 | $-1,539 | $-695 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 3,500 | -3,500 | N/A | N/A |
| PPE Investments | -3 | -29 | -70 | -17 | -9 |
| Purchase Of Investment | 4 | -3 | -20 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 49 | 0 | 0 |
| Investing Cash Flow | $1 | $3,468 | $-3,541 | $-17 | $-9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,304 | 4,339 | 3,870 | 11,902 | 508 |
| Other Financing Activity | -391 | -364 | -175 | 0 | 0 |
| Financing Cash Flow | $10,913 | $3,975 | $3,695 | $11,902 | $508 |
| Exchange Rate Effect | -41 | 8 | -88 | 18 | N/A |
| Beginning Cash Position | 2,640 | 3,543 | 11,063 | 699 | 895 |
| End Cash Position | 3,378 | 2,640 | 3,543 | 11,063 | 699 |
| Net Cash Flow | $738 | $-903 | $-7,520 | $10,364 | $-196 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,135 | -8,354 | -7,586 | -1,539 | -695 |
| Capital Expenditure | -3 | -29 | -70 | -17 | -9 |
| Free Cash Flow | -10,138 | -8,383 | -7,656 | -1,556 | -704 |